Success Metrics

Clinical Success Rate

84.6%

Based on 33 completed trials

Completion Rate

85%(33/39)

Active Trials

12(20%)

Results Posted

79%(26 trials)

Terminated

6(10%)

Phase Distribution

Ph phase_2

39%

Ph not_applicable

12%

Ph phase_4

Ph phase_3

10%

Ph early_phase_1

10%

Ph phase_1

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution59 total trials

Early Phase 1First-in-human

6(10.2%)

Phase 1Safety & dosage

12(20.3%)

Phase 2Efficacy & side effects

23(39.0%)

Phase 3Large-scale testing

6(10.2%)

Phase 4Post-market surveillance

5(8.5%)

N/ANon-phased studies

7(11.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

78.6%

33 of 42 finished

Non-Completion Rate

21.4%

9 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(14)

Completed(33)

Terminated(9)

Other(3)

Detailed Status

Completed33

Recruiting9

Terminated6

Active, not recruiting3

unknown3

Withdrawn3

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

84.6%

Most Advanced

Phase 4

Trials by Phase

Early Phase 16 (10.2%)

Phase 112 (20.3%)

Phase 223 (39.0%)

Phase 36 (10.2%)

Phase 45 (8.5%)

N/A7 (11.9%)

Trials by Status

recruiting915%

terminated610%

active_not_recruiting35%

completed3356%

not_yet_recruiting23%

unknown35%

withdrawn35%

Recent Activity

12 active trials

Showing 5 of 59

not_yet_recruitingphase_2

Clinical Trials (59)

Showing 20 of 59 trialsScroll for more

NCT07231965Phase 2

Synthetic THC And Blood Pressure

Not Yet Recruiting

NCT07225777Phase 2

Sex Differences in Neurobehavioral Response to THC

Recruiting

NCT04374773Phase 4

Effects of Pregnancy-associated Hormones on THC Metabolism in Women

Completed

NCT07570953Phase 2

A Study Of Synthetic THC And Sleep

Not Yet Recruiting

NCT04025359Early Phase 1

Effects of Dronabinol in Opioid Maintained Patients

Recruiting

NCT06454669Phase 2

Dronabinol as an Adjunct for Reducing Pain

Recruiting

NCT03560934Early Phase 1

Tetrahydrocannabinol (THC) and Sleep

Completed

NCT05865470Phase 1

Age-dependent Effects of Smoked and Oral Delta-9-THC

Recruiting

NCT01964404Phase 1

Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment?

Completed

NCT06731894Phase 2

Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors

Recruiting

NCT02069366Not Applicable

Cannabinoid Control of Fear Extinction Neural Circuits in Post-traumatic Stress Disorder

Completed

NCT05519111Phase 2

Cannabinoids for the Reduction of Inflammation and Sickle Cell Related Pain

Recruiting

NCT06477952Phase 1

DRonabinol Treatment of OSA

Recruiting

NCT05820685Phase 4

Dronabinol On the Pain Experience

Terminated

NCT02811510Phase 1

Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study I

Recruiting

NCT05335252Phase 3

Dronabinol After Arthroscopic Surgery

Recruiting

NCT06146101Phase 2

RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSA

Active Not Recruiting

NCT04871269Not Applicable

The Effect of Dronabinol on the Acquisition and Consolidation of Trauma-Associated Memories

Active Not Recruiting

NCT03804840Early Phase 1

Developing a Mobile Method to Measure THC-induced Impairment

Completed

NCT02310347Not Applicable

Influence of a Medicinal Cannabinoid Agonist on Responses to Food Images and Food Intake

Active Not Recruiting

Drug Details

Intervention Type: DRUG
Total Trials: 59